Latest Posts
May 17, 2017
More than 50 million Americans suffer from infections every year, including Wound, Nail, Urinary, Joint and Sinus Infections. Research has shown infections that are not cleared can move to a biofilm phenotype creating a barrier to healing and lead to a chronic infection disease state. These chronic infections are not caused by “single pathogens” but rather “Biofilms” or “Collaborative Communities” of multiple species of bacteria and fungi. We now know there are over 50,000 species of microbes and 99% of them can not be identified using the traditional culture method. Next Generation DNA Sequencing is the gold standard in […]
May 10, 2017
Dr. Matthew Regulski was kind enough to sit down and discus his experience with MicroGen DX*. Dr. Matthew Regulski can be found at Ocean County Foot and Ankle Surgical Associates in Toms River New Jersey (contact information below). “I run all the clinical research, wound healing program that we do here,” Dr. Regulski told us. “Mainly do a lot of limb salvage, diabetic foot reconstruction, wound healing. Been doing it for 12 years.” We asked Dr. Regulski to recall his first impressions when he heard about what MicroGen DX could do for his patients. “When somebody comes to you and […]
May 10, 2017
We sat down recently to talk to Dr. Laurence O’Halloran, an otolaryngologist, head and neck surgeon in Northern Virginia. He shared with us a story about a patient named Cathy who had previously suffered for many years with chronic sinus issues. After using Next Generation DNA sequencing to determine the root cause of her chronic condition with MicroGen DX*, Dr. O’Halloran was able to provide targeted treatment for Cathy which has lead to her experiencing great improvement. “I see a lot of patients with chronic sinusitis,” Dr. O’Halloran told us. “Cathy is a patient of mine. She had chronic sinusitis, approximately […]
May 2, 2017
We were recently fortunate to talk with Michael Waters, DO, a urologist practicing in the coastal Alabama region about his success using MicroGen DX for his clinical decision-making. “I have number of patients who’ve come to me who I’m certain have an infection,” he told us. “They’re symptomatic. In my practice, average of 30-35% of cultures have returned no growth when I’m actually certain the patient does have an infection. What was most surprising for me is the results I got back. How eye opening it was, especially patients with chronic illness, chronic infections.
May 2, 2017
We were fortunate enough to be able to sit down with Javad Parvizi recently for an interview. Javad Parvizi, MD is a professor of Orthopedic Surgery at Rothman Institute at Thomas Jefferson University. He has been in practice for over 15 years, doing mostly hip and knee replacement with an interest in periprosthetic joint infection. “We are in desperate need of innovation that will help us to do better for these patients,” Dr. Parvizi told us. “But what we also face is diagnosis of periprosthetic joint infection is very difficult. It is difficult for two reasons.